Literature DB >> 27261592

Investigation of the anti-glioma activity of Oviductus ranae protein hydrolysate.

Xin Sui1, Xiao-Hua Li1, Ming-Hua Duan1, Ai-Ling Jia1, Ye Wang1, Da Liu1, Yi-Ping Li2, Zhi-Dong Qiu1.   

Abstract

Oviductus Ranae is the dry oviducts of Rana temporaria chensinensis, and it has been reported to have a range of biological activities. This study aimed to investigate the effects of Oviductus Ranae protein hydrolysate (ORPH) on human glioma C6 cell proliferation and apoptosis in vitro and in vivo. Following in vitro treatment, cell viability and colony formation assays showed that ORPH inhibited C6 cell proliferation. In addition, the results of western blotting also demonstrated that ORPH effectively regulated the expression of the apoptosis related proteins, cleaved caspase-3, Bax and Bcl-2, DNA staining and flow cytometry analysis demonstrated that ORPH significantly promoted apoptosis in this cell line, a finding that was confirmed in vivo using terminal deoxynucleotidyl transferase dUTP nick end labeling. Further investigation demonstrated that ORPH increased apoptosis by modulating the release of inflammatory cytokines and the phosphoinositide 3-kinase (PI3K)/AKT signaling pathway; this was demonstrated using a PI3K/AKT inhibitor (NVP-BEZ235). In summary, the present study suggested that ORPH promoted apoptosis and inhibited glioma cell proliferation by influencing the PI3K/AKT signaling pathway.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Glioma cells; Oviductus ranae; Oviductus ranae protein hydrolysate; PI3K/AKT

Mesh:

Substances:

Year:  2016        PMID: 27261592     DOI: 10.1016/j.biopha.2016.04.015

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  1 in total

1.  Structural analysis of glycosaminoglycans from Oviductus ranae.

Authors:  Haiyue Huang; Jin Mao; Quntao Liang; Jianghui Lin; Lilong Jiang; Shutao Liu; Joshua S Sharp; Zheng Wei
Journal:  Glycoconj J       Date:  2021-01-07       Impact factor: 2.916

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.